Large nosocomial epidemics involving AmpC-producing Klebsiella pneumoniae strains have never been reported to date. The first reported nosocomial outbreak due to AmpCproducing K. pneumoniae strains occurred at the Miriam Hospital (Rhodes, Greece) in 1988 and involved 11 patients (8) . A number of other outbreaks have since been described, but they rarely involved more than 10 individuals (7). We report the largest outbreak involving a plasmid-encoded AmpC-producing K. pneumoniae strain and the first such case in a department of physical medicine and rehabilitation (PMR).
The Raymond Poincaré hospital (Garches, France) is a 440-bed teaching hospital that includes a 150-bed PMR department caring for patients with motor impairment. In November 1999, a 26-year-old patient with tetraplegia transferred from Tunisia to the PMR department was found to have urine samples positive for an ACC-1-producing K. pneumoniae strain. After the identification of three other cases from January to March 2000 in the PMR department, the screening policy used for the detection of extended-spectrum ␤-lactamase-producing organisms by rectal swabbing and inoculation of Drigalski agar plates containing 0.5 ml/liter of cefotaxime (1) was extended to ACC-1-producing K. pneumoniae strains. Oxidase-negative colonies detected on cefotaxime selection plates were tested with the disk diffusion method (3) for susceptibility to ticarcillin-clavulanate, ceftazidime, cefotaxime, aztreonam, cefepime, cefoxitin, and cefotetan. Epidemic ACC-1-producing K. pneumoniae was suspected in the presence of the susceptibility pattern shown in Fig. 1 .
The epidemic involved a total of 57 cases (at least one clinical sample and/or rectal swab positive for ACC-1-producing K. pneumoniae) from September 1999 to May 2003, mainly in the PMR department (46 cases) but also in other hospital units (surgical intensive care unit, 7 cases; medical intensive care unit, 3 cases; and septic orthopedic surgery, 1 case). The epidemic was controlled by strictly isolating carriers of ACC-1-producing K. pneumoniae, a measure implemented only at a late stage because it is in contradiction with our reeducation strategy. ACC-1-producing K. pneumoniae isolates were detected in diagnostic cultures (12 cases), screening cultures (24 cases), or both (21 cases). Nineteen patients met the criteria for nosocomial infection (4) (urinary tract infection, 16 cases; pyelonephritis with bloodstream infection, 2 cases; and paravertebral abscess, 1 case). The mean (Ϯ the standard deviation) delay between admission and the first positive sample was 28 (Ϯ40) days (range, 1 to 229 days). Most patients were male (sex ratio, 0.86). The median age was 34 years (range, 17 to 94 years). All patients had a neurological disease, mostly spinal cord injury.
All ACC-1-producing K. pneumoniae isolates collected during the outbreak showed the same pattern of resistance to ␤-lactams with the disk diffusion method and were resistant to gentamicin, tobramycin, netilmicin, trimethoprim-sulfamethoxazole, and rifampin; most isolates were resistant to tetracycline and/or intermediate or resistant to ciprofloxacin. MICs of ceftazidime, cefotaxime, cefoxitin, cefotetan, and cefepime were determined by the agar dilution method on the first ACC-1-producing K. pneumoniae isolates recovered from cases 1 to 12. The results confirmed the results of previous disk diffusion susceptibility tests (Table 1 ) and suggested the presence of an AmpC-type enzyme, most likely an ACC-1 enzyme because of the susceptibility to cefoxitin (2) .
The first isolates recovered from cases 1, 2, and 3 (referred to as isolates 1, 2, and 3, respectively) were each tested for the ability to transfer ceftazidime resistance to Escherichia coli K12C600 (Str r ) by conjugation and to E. coli NM554 (Str r ) by transformation. Transconjugants and transformants were selected on Drigalski agar plates containing streptomycin (100 mg/liter) and ceftazidime (10 mg/liter). Transconjugants (obtained only with isolate 2) and transformants displayed the same pattern of resistance to ␤-lactam agents as the donor K. pneumoniae isolates. Other resistance markers were cotransferred: (i) gentamicin, tobramycin, and netilmicin (isolates 1, 2, and 3); (ii) rifampin (isolates 1, 2, and 3); (iii) sulfamethoxazole (isolates 1 and 2); (iv) trimethoprim (isolate 3); and (v) tetracycline (isolate 3). Each of the transconjugants and transformants contained a single additional plasmid of approximately 100 kb (data not shown), suggesting that all of the transferred resistance genes were carried by this genetic element.
PCR was carried out on the epidemic K. pneumoniae isolates 1 to 3 and their transconjugants and transformants in E. coli using the sets of primers ACC3-ACC2, SHV01-SHV02, and TEMA1-TEMB1 ( Table 2 ). The amplification conditions were 45 cycles of 30 s at 94°C, 30 s at the annealing temperature, and 30 s at 72°C and a final extension step at 72°C for 10 min. The PCR products were sequenced with the Big Dye terminator sequencing kit (Perkin-Elmer/Applied Biosystems, Courtaboeuf, France) using the primers listed in Table 2 and an ABI Prism sequencer (Perkin-Elmer/Applied Biosystems). The three K. pneumoniae isolates and their transconjugants and transformants yielded an amplicon of 1,276 bp with the primer set ACC3-ACC2, which was identical to the first ACC-1 K. pneumoniae gene described (2) . PCR studies also revealed the presence of a bla SHV gene in epidemic K. pneumoniae isolates but not in the transconjugants and transformants and of a bla TEM gene, identified as a bla TEM1B (Pa/Pb) gene by sequencing, both in the epidemic isolates and in their transconjugants and transformants.
ACC-1-producing K. pneumoniae isolates were characterized by random amplified polymorphic DNA (RAPD) and pulsed-field gel electrophoresis (PFGE) analysis of XbaI-digested DNA. RAPD was carried out as previously described using the primers HLWL74 (5Ј-ACGTATCTGC-3Ј) and R108 (5Ј-GTATTGCCCT-3Ј) (5). PFGE was carried out using the GenePath system with a CHEF DRII apparatus (Bio-Rad Laboratories, Marnes-la-Coquette, France), as previously described (13) . All of the epidemic ACC-1-producing K. pneumoniae isolates analyzed shared the same RAPD profile and were of the same PFGE pulsotype according to Tenover et al. (13) (data not shown) . This is the first large, nosocomial outbreak involving a unique strain of K. pneumoniae producing a plasmid-mediated AmpC ␤-lactamase. The epidemic strain harbored a plasmidborne bla ACC-1 gene, known to be derived from the chromosomal bla gene of Hafnia alvei (9) . This strain was imported from a region of Tunisia that constitutes a persistent focus of multidrug-resistant K. pneumoniae strains, including strains harboring the plasmid-borne bla ACC-1 gene (11) . The fact that our institution is geared toward the rehabilitation of patients with motor impairment probably strongly affected the dissemination of the strain in an endemic-epidemic manner, with transfers and prolonged stays of patients providing mobile reservoirs for bacteria (6) .
We thank S. Geoffroy, C. Wippf, and I. Sénegas for their contribution to this work.
